Table 3. Adverse events after 30 cycles of .
Adverse event | Latent | Sub-acute | ||
---|---|---|---|---|
All grades | Grade 3 | All grades | Grade 3 | |
Renal | ||||
Glomerular filtration rate (GFR) | 8 (53%) | 0 | 1 (7%) | 0 |
Tubular extraction rate (TER) | 2 (13%) | 0 | - | - |
Hyperkalemia | 4 (27%) | 0 | 0 | 0 |
Hematologic | ||||
Anemia | 3 (20%) | 0 | 9 (60%) | 1 (7%) |
Thrombocytopenia | 2 (13%) | 0 | 1 (7%) | 0 |
Leukocytes | 7 (47%) | 1 (7%) | 1 (7%) | 0 |
Liver | ||||
Bilirubin | 0 | 0 | 1 (7%) | 0 |
AST/ALT | 2 (13%) | 0 | 1 (7%) | 0 |
Other | ||||
Fatigue | 5 (33%) | 0 | 0 | 0 |
Dry mouth | 7 (47%) | 0 | 0 | 0 |
Nausea | 5 (33%) | 1 (7%) | 0 | 0 |
Dysgeusia | 3 (20%) | 0 | 0 | 0 |
Absolute number of adverse events (%) are given.